Replies to post #78081 on MedGen Inc (MDIN)

[Traderboy1966]

Start here:
patent:
http://www.celprogen.com/image/data/Patent.pdf

http://ih.advfn.com/p.php?pid=nmona&article=57763881

http://www.otcmarkets.com/stock/MDIN/news/Northstar-acquires-a-new-and-exciting-patent-license-in-a-multi-billion-dollar-industry?id=63714&b=y

Previous post on this board:
First, this shows the patent is real:
http://www.celprogen.com/image/data/Patent.pdf
and that Celprogen obtained it last fall:
http://www.businesswire.com/news/home/20120926006325/en/Celprogen-Obtained-Patent-US8236297B2-Method-Treating-Lactose

Then, this shows that MDIN got the exclusive license to use it:
http://www.prnewswire.com/news-releases/northstar-acquires-a-new-and-exciting-patent-license-in-a-multi-billion-dollar-industry-209327661.html

If the patent deal never happened, or if the terms of it weren't accurate, wouldn't Celprogen have responded to this PR by now, setting it straight? Given the terms of the PR, they'll have to declare themselves as major shareholders in MDIN, so if it's not true, they'll be very vocal about it.
So the patent license deal is real, and probably worth a lot, maybe enough to make MDIN a target of acquisition.

Now, HERE'S THE CLINCHER!
Again, think from the perspective of Celprogen and Kenneth Manzo.
If they thought MDIN's products/business might be a scam, wouldn't they have insisted on cash for this deal, instead of insisting on shares in the company, as they did?
Since they sold the rights for just shares, don't you think that during negotiatinos, they insisted on access to a firsthand, direct look at the company's operations and sales, etc., so they could be sure it was all legit and worth something, before agreeing to the deal?

Don't you think that Celprogen & Ken Manzo feel 100% sure that MDIN is legit, and not a scam?

These guys are smart and informed, so if it's good enough for them, it's good enough for me!


HOLBROOK, N.Y., May 29, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTCPink: MDIN), today announced that after lengthy negotiations, it has closed a deal with the owners, and inventors of one of the most exciting health related patented processes in the US today. The patent, titled: "Method of treating lactose intolerance using genetically engineered bacteria," covers a process for the creation of a product that when ingested, has been shown to have the potential of completely alleviate the symptoms of lactose intolerance. The product, developed in partnership with Celprogen, Inc. by it's co-inventor, pharmacist Kenneth Manzo, showed that when tested in laboratory rats, their intolerance for lactose-based foods disappeared for up to three months without taking additional doses of the product.

Lactose intolerance is the inability to digest milk and milk products, and may cause symptoms ranging from mild to severe abdominal pain, abdominal bloating, gas, diarrhea, and nausea. The only treatment for this condition is to either avoid lactose-containing foods and drinks altogether, or to take over the counter pills before or immediately after the food is consumed. Often lactose intolerant people may forget to take their pills, not have any on them or accidentally consume something with lactose and the result is illness and a severe disruption of everyday life.

This patent has the potential to make all of that discomfort and disruption a thing of the past. A single dose of the product produced using this patented method would basically change the person's digestive system's behavior to that of someone without lactose intolerance for up the three months at a time. This would allow the individual to eat anything they please without taking a single pill. Considering the difficulty and cost associated with current over the counter treatments, Northstar feels the potential of this product is almost limitless, and if executed properly could put the company in a position of changing millions of lives for the better.

[flaflyersfan]

Taka86, Manzo Pharmaceuticals;

https://www.facebook.com/manzopharma?hc_location=timeline

https://twitter.com/ManzoPharma

Business Name History

--------------------------------------------------------------------------------

Name Name Type
MANZO PHARMACEUTICALS LLC Current Name

--------------------------------------------------------------------------------

Limited Liability Company - Domestic - Information

Entity Number: 4226631
Status: Active

Entity Creation Date: 11/12/2013

State of Business.: PA
Registered Office Address: 125 Timber Ridge Dr
Shohola PA 18458
Pike
Mailing Address: No Address

Good luck.

[CraigT23]

Start by looking under Celprogen!!!!